LLMpediaThe first transparent, open encyclopedia generated by LLMs

Patient-Centered Outcomes Research Institute

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 65 → Dedup 4 → NER 3 → Enqueued 1
1. Extracted65
2. After dedup4 (None)
3. After NER3 (None)
Rejected: 1 (not NE: 1)
4. Enqueued1 (None)
Similarity rejected: 1
Patient-Centered Outcomes Research Institute
NamePatient-Centered Outcomes Research Institute
Formation2010
HeadquartersWashington, D.C.
Leader titleChief Executive Officer

Patient-Centered Outcomes Research Institute The Patient-Centered Outcomes Research Institute was established to fund comparative clinical effectiveness research and to prioritize stakeholder-centered approaches in health studies. The institute emerged from legislative action and interacts with agencies, academic centers, and healthcare systems to inform clinical decision-making and policy debates. Its work intersects with clinical trials, evidence synthesis, health services research, and stakeholder engagement across major institutions.

History

The institute traces its origins to the passage of the Affordable Care Act and subsequent legislative authorization, reflecting debates in the United States Senate, the United States House of Representatives, and among advocates associated with American Medical Association, American Hospital Association, and patient advocacy groups like American Cancer Society. Early leadership engaged with federal agencies including the Department of Health and Human Services and the National Institutes of Health to align priorities with existing programs such as the Agency for Healthcare Research and Quality, while coordinating with academic centers like Johns Hopkins University, Harvard School of Public Health, and Stanford University. Key events in its formation included policy discussions during presidencies of Barack Obama and interactions with congressional committees chaired by members such as Max Baucus and Orrin Hatch. Notable milestones involved rulemaking and governance setup that paralleled reforms modeled in other institutional efforts like Centers for Medicare and Medicaid Services demonstration projects and comparative effectiveness initiatives inspired by the Institute of Medicine.

Mission and Governance

The institute’s mission emphasizes patient-centered outcomes research informed by stakeholders including clinicians from Mayo Clinic, researchers from Cleveland Clinic, representatives from American Academy of Family Physicians, and patient groups modeled after organizations like PatientsLikeMe. Governance structures incorporate a Board of Governors and a Methodology Committee analogous to boards found at Wellcome Trust and Howard Hughes Medical Institute, and leadership has interacted with figures from think tanks such as Brookings Institution and policy organizations including Kaiser Family Foundation. Executive appointments and oversight involve confirmation-like processes and reporting relationships that mirror practices at institutions like Smithsonian Institution and Federal Reserve Board for accountability and transparency.

Funding and Research Priorities

Funding mechanisms draw upon an assessment process akin to prioritization used by National Health Service agencies, targeting comparative effectiveness studies similar to trials run at Mayo Clinic and multicenter collaborations involving Veterans Health Administration networks. Research priorities include chronic diseases exemplified by projects on diabetes mellitus, heart failure, and chronic obstructive pulmonary disease conducted with partners such as University of California, San Francisco and Massachusetts General Hospital. Investment strategies echo grant programs at Gates Foundation and coordination efforts resembling multi-stakeholder consortia like ClinicalTrials.gov-linked networks, with funding announcements aligning with methodological guidance from bodies including Cochrane Collaboration and Agency for Healthcare Research and Quality.

Methods and Patient Engagement

Methodological standards emphasize comparative effectiveness research, randomized pragmatic trials, and observational studies using data sources such as electronic health records from Epic Systems Corporation implementations, registries like Society of Thoracic Surgeons databases, and claims datasets from payers comparable to Blue Cross Blue Shield. Patient engagement practices follow models established by National Patient Safety Foundation and participatory initiatives like Community-Campus Partnerships for Health, incorporating patients and caregivers akin to advocates from Susan G. Komen for the Cure and organizations such as National Multiple Sclerosis Society. The institute’s Methodology Committee sets standards reflecting practices from CONSORT and STROBE statements and interacts with academic methodologists at Columbia University, Yale School of Medicine, and University of Pennsylvania.

Impact and Notable Projects

Notable projects include comparative studies on treatments used in oncology centers such as Dana-Farber Cancer Institute, cardiovascular studies involving investigators at Cleveland Clinic and Brigham and Women's Hospital, and pragmatic trials implemented through health systems like Kaiser Permanente and Intermountain Healthcare. Findings have informed clinical guidelines developed by organizations such as American College of Cardiology and American Diabetes Association, and influenced coverage discussions at Centers for Medicare and Medicaid Services. Collaborations with registries and networks echo partnerships seen with PCORnet and large-scale data initiatives similar to those at All of Us Research Program.

Criticisms and Controversies

Criticism has arisen from policy makers and stakeholders including members of United States Congress and advocacy groups who questioned funding priorities and potential influence on clinical practice, paralleling controversies surrounding Institute for Clinical and Economic Review and debates over the Affordable Care Act implementation. Concerns have involved interactions with industry partners such as pharmaceutical companies represented in forums including PhRMA, debates about influence similar to disputes involving Gates Foundation funding, and legal and political scrutiny reminiscent of hearings held by committees chaired by figures like Darrell Issa. Methodological critiques have been raised by researchers from institutions like University of Michigan and think tanks including Heritage Foundation, focusing on prioritization, transparency, and stakeholder representation.

Category:Organizations established in 2010